Stream 6 Session #4: Free communications- Pathophysiology of metabolic disease
Tracks
Meeting Room 111 & 112
| Wednesday, August 19, 2026 |
| 11:00 AM - 12:30 PM |
| Meeting Room 111 & 112 (Level 1) |
Speaker
Dr Mahesh Umapathysivam
Endocrinologist
Southern Adelaide Diabetes and Endocriine service
Chairperson
Biography
Dr Ashwin Karuppan Vishwanathan
Medical Director
Tambaram Medical Center
BCSI-T2DA Novel β-Cell stress index to guide timely insulin initiation in Type 2 Diabetes
11:00 AM - 11:15 AMBiography
Dr. V. Ashwin Karuppan is a senior clinician with over 17 years of experience in internal medicine and diabetology. A Fellow of FRCP (Glasg),FCMA, and IDF, with international memberships (ACP, EASD), he has led 50+ research projects, published extensively, earned multiple awards, provided philanthropic care, and demonstrated sustained academic leadership
Dr Dongni Yu
Chief Physician
Beijing Hospital
5:2 Intermittent fasting with meal replacement improves TyG index and insulin resistance in early Type 2 Diabetes: A post hoc analysis of the EARLY trial
11:15 AM - 11:30 AMBiography
Dr. Dongni Yu is an Chief Physician in the Department of Endocrinology at Beijing Hospital, China. Her clinical and research interests focus on metabolic diseases, particularly diabetes and obesity management. She is actively involved in clinical trials and patient education to improve metabolic health outcomes.
Dr Cong Xie
Research Fellow
Adelaide University
The insulinotropic response to endogenous GIP in people with suboptimally controlled type 2 diabetes before and after 12 weeks of sitagliptin treatment
11:30 AM - 11:45 AMBiography
Dr Cong Xie is an early career post-doc at Adelaide University in research focusing on understanding the key role of the gut and taste signalling in glucose metabolism in both health and type 2 diabetes and the translation of these novel insights into improved therapy for type 2 diabetes.
Dr Andrzej Januszewski
Senior Research Fellow
University of Sydney
Socioeconomic status modifies triglyceride-rich lipoprotein response to fenofibrate in the FIELD trial
11:45 AM - 12:00 PMBiography
Dr Andrzej Januszewski is a clinician-researcher at the University of Sydney focused on diabetes complications, insulin resistance, cardiovascular risk and biomarkers. His work integrates clinical trials, epidemiology and socioeconomic data to address health equity and access to care. He developed multiple online tools to improve risk prediction and doctor–patient communication.
Dr Ghizal Fatima
Associate Professor
Era University
Chronogenetic and hormonal rhythm alterations in adolescent metabolic syndrome: Implications for early chronotherapeutic intervention
12:00 PM - 12:15 PMBiography
Dr. Ghizal Fatima is an Associate Professor and Head of the Chronobiology Unit at ERA Medical College, Lucknow. Her research focuses on circadian biology, chronogenetics, and biomarker-based precision medicine, with extensive experience in translational research, international collaborations, and academic leadership in biomedical sciences.
Dr Chunjie Xiang
Postdoc
Southest University
Serum bile acid response to an oral glucose load is exaggerated in newly diagnosed, treatment-naive, Chinese with type 2 diabetes and reduced by insulin-pump therapy
12:15 PM - 12:30 PMBiography
Chunjie Xiang is a postdoctoral researcher at Zhongda Hospital, Southeast University, Nanjing. Her research focuses on gastrointestinal physiology and glycaemic control in health and type 2 diabetes, with an emphasis on translational and clinical research.
